Dry eye disease is an ocular condition where the eyes do not produce enough tears or make the right type of tears or tear film. It is estimated that there are approximately 39 million dry eye disease patients in the United States.
The stock we are bringing to your attention today is that of Aldeyra Therapeutics Inc. (ALDX), which despite facing an initial setback in obtaining FDA approval for its investigational dry eye disease treatment last year, is set to make another attempt later this year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.